Published in J Med Microbiol on December 01, 1998
Serratia infections: from military experiments to current practice. Clin Microbiol Rev (2011) 2.90
Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2. Infect Immun (2006) 1.04
Insecticidal potency of bacterial species Bacillus thuringiensis SV2 and Serratia nematodiphila SV6 against larvae of mosquito species Aedes aegypti, Anopheles stephensi, and Culex quinquefasciatus. Parasitol Res (2011) 0.91
Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens. Infect Immun (2002) 0.89
Bacteriophage ϕMAM1, a viunalikevirus, is a broad-host-range, high-efficiency generalized transducer that infects environmental and clinical isolates of the enterobacterial genera Serratia and Kluyvera. Appl Environ Microbiol (2014) 0.86
Serratia marcescens necrotizing fasciitis presenting as bilateral breast necrosis. J Clin Microbiol (2012) 0.80
Purification and properties of a novel insecticidal protein from the locust pathogen Serratia marcescens HR-3. Curr Microbiol (2005) 0.79
Cloning, expression, and purification of insecticidal protein Pr596 from locust pathogen Serratia marcescens HR-3. Curr Microbiol (2007) 0.79
Marvelous but Morbid: Infective endocarditis due to Serratia marcescens. Infect Dis Clin Pract (Baltim Md) (2016) 0.75
Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol (1996) 3.52
Imported melioidosis in England and Wales. Lancet (1999) 3.42
Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect (2007) 3.00
Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol (2005) 2.95
The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes. J Gen Microbiol (1973) 2.61
Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother (1998) 2.51
Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol (1995) 2.43
Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun (1984) 2.39
Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J Clin Microbiol (1993) 2.38
Pilus-dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. J Gen Virol (1974) 2.23
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1996) 2.11
Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae. J Clin Microbiol (1991) 2.06
Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol (1995) 1.87
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect (2004) 1.74
2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother (1992) 1.71
Latex agglutination test for identification of Pseudomonas pseudomallei. J Clin Pathol (1993) 1.67
The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol (1996) 1.52
Burkholderia pseudomallei and Indian plague-like illness. Lancet (1995) 1.44
Ribotype differences between clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1997) 1.38
Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis. J Clin Microbiol (1993) 1.37
Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax (1993) 1.37
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax (2000) 1.37
A comparison of flagellar typing and phage typing as means of subdividing the O groups of Pseudomonas aeruginosa. J Med Microbiol (1981) 1.34
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. J Hosp Infect (1995) 1.31
The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera. J Med Microbiol (1978) 1.29
The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals. J Hyg (Lond) (1980) 1.24
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol (1986) 1.23
Preparation of agglutinating antisera specific for the flagellar antigens of Pseudomonas aeruginosa. J Med Microbiol (1981) 1.22
Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol (1996) 1.22
Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol Lett (1992) 1.21
New bacteriophage typing scheme for subdivision of the frequent capsular serotypes of Klebsiella spp. J Clin Microbiol (1987) 1.17
Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Thorax (2002) 1.14
Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol (1995) 1.14
Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. J Hosp Infect (1999) 1.14
PSE-4 beta lactamase: a serotype-specific enzyme in Pseudomonas aeruginosa. J Med Microbiol (1985) 1.12
Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J R Soc Med (1986) 1.12
O serotyping scheme for Enterobacter cloacae. J Clin Microbiol (1983) 1.12
An outbreak of melioidosis in imported primates in Britain. Vet Rec (1992) 1.11
State of the art: typing Pseudomonas aeruginosa. J Hosp Infect (1980) 1.11
Stability of strain genotypes of Burkholderia pseudomallei from patients with single and recurrent episodes of melioidosis. Trop Med Int Health (1998) 1.08
Latex agglutination for rapid detection of Pseudomonas pseudomallei antigen in urine of patients with melioidosis. J Clin Pathol (1995) 1.05
Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring? J Hosp Infect (1992) 1.04
Dissociation of surface properties and "intrinsic" resistance to beta lactams in Pseudomonas aeruginosa. J Med Microbiol (1986) 1.04
A comparison of typing methods for Serratia marcescens. J Hyg (Lond) (1977) 1.02
Epidemiologically related and unrelated strains of Pseudomonas aeruginosa serotype O12 cannot be distinguished by phenotypic and genotypic typing. J Hosp Infect (1997) 1.02
A method for the detection of gelatinase production by bacteria. J Appl Bacteriol (1970) 1.00
Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli. J Clin Pathol (1999) 1.00
Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2008) 0.98
Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens. Epidemiol Infect (1993) 0.98
Infection with netilmicin resistant Serratia marcescens in a special care baby unit. Br Med J (Clin Res Ed) (1983) 0.98
Molecular typing of Myroides odoratimimus (Flavobacterium odoratum) urinary tract infections in a Turkish hospital. Eur J Clin Microbiol Infect Dis (2000) 0.96
Regional microbiology of the cystic fibrosis lung: a post-mortem study in adults. J Infect (1998) 0.94
Imipenem resistance in Proteus mirabilis. J Antimicrob Chemother (1991) 0.94
An immunological study of the pili of Pseudomonas aeruginosa. J Hyg (Lond) (1975) 0.94
O-antigen specificities of the serotype strains of Serratia marcescens. J Clin Microbiol (1989) 0.93
European-wide distribution of Pseudomonas aeruginosa clone C. Clin Microbiol Infect (2003) 0.93
Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros (2007) 0.93
Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis. Thorax (1992) 0.92
Rapid extraction of high purity chromosomal DNA from Serratia marcescens. Lett Appl Microbiol (1993) 0.92
Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes. J Immunol (1991) 0.91
Lipopolysaccharide profile typing as a technique for comparative typing of gram-negative bacteria. J Clin Microbiol (1993) 0.91
Pseudomonas aeruginosa colonisation in an intensive therapy unit: role of cross infection and host factors. Br Med J (Clin Res Ed) (1983) 0.91
Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera. Eur J Clin Microbiol (1985) 0.91
Epidemiology of Pseudomonas aeruginosa infection in cystic fibrosis and the use of strain genotyping. J Infect (1993) 0.91
Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media. J Clin Pathol (1986) 0.90
State of the art: typing of Serratia marcescens. J Hosp Infect (1982) 0.90
State of the art in typing: Klebsiella spp. J Hosp Infect (1990) 0.90
Bacterial typing systems: the way ahead. J Med Microbiol (1994) 0.90
Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance. J Med Microbiol (1991) 0.90
Evaluation of a nine-locus variable-number tandem-repeat scheme for typing of Pseudomonas aeruginosa. Clin Microbiol Infect (2009) 0.90
Persistence of Pseudomonas aeruginosa strains in respiratory infection in AIDS patients. AIDS (1998) 0.89
In vitro susceptibility of hospital isolates of various bacterial genera to chlorhexidine. J Hosp Infect (1983) 0.88
Serotypes and biochemical profiles of British hospital strains of Enterobacter cloacae in relation to site of infection and antibiotic susceptibility. J Hosp Infect (1987) 0.87
Serological relationships of the O antigens of Klebsiella pneumoniae O5, Escherichia coli O8 and a new O serotype of Serratia marcescens. FEMS Microbiol Lett (1991) 0.86
Subdivision of O serotypes of Pseudomonas aeruginosa with monoclonal antibodies. J Clin Microbiol (1988) 0.86
Epidemiological typing of Enterobacter aerogenes. J Clin Microbiol (1989) 0.86
The antibody response to the flagella of Pseudomonas aeruginosa. J Med Microbiol (1975) 0.85
Improved O-serotyping method for Serratia marcescens. J Clin Microbiol (1989) 0.85
Nosocomial Acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med (1999) 0.84
Diversity of klebsiellae with extended-spectrum beta-lactamases at a Turkish university hospital. J Hosp Infect (1992) 0.84
Prevalence of a plasmid-mediated type II dihydrofolate reductase gene among trimethoprim-resistant urinary pathogens in Greek hospitals. J Antimicrob Chemother (1992) 0.83
Types of Pseudomonas aeruginosa isolated from horses. Equine Vet J (1982) 0.81
Colonisation of lung allografts with Pseudomonas aeruginosa in heart-lung transplant recipients with cystic fibrosis. Thorax (1994) 0.81
Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa. J Med Microbiol (1983) 0.80
Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli. Clin Microbiol Infect (2006) 0.80
Pseudobacteraemia and ESR bottles. J Hosp Infect (1982) 0.80
Immunochemical characterization of two new O serotypes of Serratia marcescens (O27 and O28). FEMS Microbiol Lett (1996) 0.79
Different O and K serotype distributions among clinical and environmental strains of Serratia marcescens. J Med Microbiol (1998) 0.79
Identification of capsular antigens in Serratia marcescens. J Clin Microbiol (1997) 0.78
Comparison of polyclonal rabbit antisera with monoclonal antibodies for serological typing of Pseudomonas aeruginosa. J Clin Microbiol (1988) 0.78
An epidemiological study of Plesiomonas shigelloides diarrhoea among Japanese travellers. Epidemiol Infect (2000) 0.78
Molecular typing of Pseudomonas pseudomallei from imported primates in Britain. Vet Rec (1994) 0.78
Antibody response of fibrocystic patients to homologous 0-typable and 0-defective isolates of Pseudomonas aeruginosa. J Clin Pathol (1990) 0.77
Serratia marcescens infection associated with early abortion in cows and buffaloes. Epidemiol Infect (1988) 0.75
Serotyping of Flavobacterium meningosepticum by co-agglutination method. Southeast Asian J Trop Med Public Health (1998) 0.75
Isolation of Serratia marcescens from an equine abortion in Germany. Vet Rec (2004) 0.75
Complementation of methionine auxotrophs of Pseudomonas aeruginosa from cystic fibrosis. Curr Microbiol (1998) 0.75